Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

Identifying Central Sensitization May Not Tell the Whole Story.

Argoff CE.

Pain Med. 2018 Oct 1;19(10):1907. doi: 10.1093/pm/pny163. No abstract available.

PMID:
30239894
2.

Opioids vs Nonopioids for Chronic Back, Hip, or Knee Pain.

Covington E, Argoff C, Stanos SP.

JAMA. 2018 Aug 7;320(5):507-508. doi: 10.1001/jama.2018.6941. No abstract available.

PMID:
30088002
3.

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 2-The Patient Assessment for Low Back Pain-Impacts (PAL-I).

Bushnell DM, Blum SI, Liedgens H, Martin ML, Freynhagen R, Wallace M, Argoff C, Eerdekens M, Kok M, Patrick DL.

Pain. 2018 Oct;159(10):2066-2075. doi: 10.1097/j.pain.0000000000001309.

4.

The CDC Opioid Guideline: Proponent Interpretation Has Led to Misinformation.

Wegrzyn EL, Chaghtai AM, Argoff CE, Fudin J.

Clin Pharmacol Ther. 2018 Jun;103(6):950-953. doi: 10.1002/cpt.1062. Epub 2018 Apr 2.

PMID:
29608033
5.

Small Fiber Polyneuropathy Is Prevalent in Patients Experiencing Complex Chronic Pelvic Pain.

Chen A, De E, Argoff C.

Pain Med. 2018 Feb 13. doi: 10.1093/pm/pny001. [Epub ahead of print]

PMID:
29447372
6.

Mixed-methods development of a new patient-reported outcome instrument for chronic low back pain: part 1-the Patient Assessment for Low Back Pain - Symptoms (PAL-S).

Martin ML, Blum SI, Liedgens H, Bushnell DM, McCarrier KP, Hatley NV, Ramasamy A, Freynhagen R, Wallace M, Argoff C, Eerdekens M, Kok M, Patrick DL.

Pain. 2018 Jun;159(6):1045-1055. doi: 10.1097/j.pain.0000000000001187.

7.

Rational Urine Drug Monitoring in Patients Receiving Opioids for Chronic Pain: Consensus Recommendations.

Argoff CE, Alford DP, Fudin J, Adler JA, Bair MJ, Dart RC, Gandolfi R, McCarberg BH, Stanos SP, Gudin JA, Polomano RC, Webster LR.

Pain Med. 2018 Jan 1;19(1):97-117. doi: 10.1093/pm/pnx285.

PMID:
29206984
8.

Opioid-sparing Effects of SoluMatrix Indomethacin in a Phase 3 Study in Patients With Acute Postoperative Pain.

Gharibo CG, Argoff C, Markenson JA, Webster LR, Nezzer J, Solorio D, Lauterio M, Young C.

Clin J Pain. 2018 Feb;34(2):138-144. doi: 10.1097/AJP.0000000000000525.

PMID:
28591082
9.

Assessment of Patient-Reported Outcome Instruments to Assess Chronic Low Back Pain.

Ramasamy A, Martin ML, Blum SI, Liedgens H, Argoff C, Freynhagen R, Wallace M, McCarrier KP, Bushnell DM, Hatley NV, Patrick DL.

Pain Med. 2017 Jun 1;18(6):1098-1110. doi: 10.1093/pm/pnw357. Review.

PMID:
28340111
10.

Pregabalin is effective in reducing fibromyalgia pain.

Argoff C.

Evid Based Med. 2017 Apr;22(2):70-71. doi: 10.1136/ebmed-2016-110630. Epub 2017 Feb 27. No abstract available.

PMID:
28242609
11.

Improvement in pain severity category in clinical trials of pregabalin.

Parsons B, Argoff CE, Clair A, Emir B.

J Pain Res. 2016 Oct 7;9:779-785. eCollection 2016.

12.

Use of Low Dose Ziconotide as First-Line Intrathecal Monotherapy.

Prusik J, Argoff C, Peng S, Pilitsis JG.

Neuromodulation. 2017 Jun;20(4):386-391. doi: 10.1111/ner.12486. Epub 2016 Aug 5.

PMID:
27492135
13.

The Effects of Mechanical and Thermal Stimuli on Local Field Potentials and Single Unit Activity in Parkinson's Disease Patients.

Belasen A, Youn Y, Gee L, Prusik J, Lai B, Ramirez-Zamora A, Rizvi K, Yeung P, Shin DS, Argoff C, Pilitsis JG.

Neuromodulation. 2016 Oct;19(7):698-707. doi: 10.1111/ner.12453. Epub 2016 Jun 10.

PMID:
27284636
14.

Pregabalin Improves Pain Scores in Patients with Fibromyalgia Irrespective of Comorbid Osteoarthritis.

Argoff CE, Emir B, Whalen E, Ortiz M, Pauer L, Clair A.

Pain Med. 2016 Nov;17(11):2100-2108. Epub 2016 Jun 1.

PMID:
27257288
15.

Rethinking chronic pain in a primary care setting.

Stanos S, Brodsky M, Argoff C, Clauw DJ, D'Arcy Y, Donevan S, Gebke KB, Jensen MP, Lewis Clark E, McCarberg B, Park PW, Turk DC, Watt S.

Postgrad Med. 2016 Jun;128(5):502-15. doi: 10.1080/00325481.2016.1188319. Review.

PMID:
27166559
16.

Effect of low-frequency deep brain stimulation on sensory thresholds in Parkinson's disease.

Belasen A, Rizvi K, Gee LE, Yeung P, Prusik J, Ramirez-Zamora A, Hanspal E, Paiva P, Durphy J, Argoff CE, Pilitsis JG.

J Neurosurg. 2017 Feb;126(2):397-403. doi: 10.3171/2016.2.JNS152231. Epub 2016 Apr 22.

PMID:
27104841
17.

Erratum to: Post-herpetic Neuralgia: a Review.

Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, Kaye AD.

Curr Pain Headache Rep. 2016 Apr;20(4):28. doi: 10.1007/s11916-016-0566-8. No abstract available.

PMID:
27002967
18.

SoluMatrix® Diclofenac: Sustained Opioid-Sparing Effects in a Phase 3 Study in Patients with Postoperative Pain.

Argoff C, McCarberg B, Gudin J, Nalamachu S, Young C.

Pain Med. 2016 Oct;17(10):1933-1941. Epub 2016 Mar 19.

PMID:
26995799
19.

Presence of Decreased Intraepidermal Nerve Fiber Density Consistent with Small Fiber Neuropathy in Patients with Central Post-Stroke Pain.

Cavalier Y, Albrecht PJ, Amory C, Bernardini GL, Argoff CE.

Pain Med. 2016 Aug;17(8):1569-71. doi: 10.1093/pm/pnw001. Epub 2016 Feb 18. No abstract available.

PMID:
26893113
20.

Post-herpetic Neuralgia: a Review.

Hadley GR, Gayle JA, Ripoll J, Jones MR, Argoff CE, Kaye RJ, Kaye AD.

Curr Pain Headache Rep. 2016 Mar;20(3):17. doi: 10.1007/s11916-016-0548-x. Review. Erratum in: Curr Pain Headache Rep. 2016 Apr;20(4):28.

PMID:
26879875
21.

The Impact of Spinal Cord Stimulation on Sleep Patterns.

Ramineni T, Prusik J, Patel S, Lange S, Haller J, Fama C, Argoff C, Pilitsis J.

Neuromodulation. 2016 Jul;19(5):477-81. doi: 10.1111/ner.12382. Epub 2016 Feb 5.

PMID:
26846456
22.

Hot Topics in Primary Care: Management of Opioid-induced Constipation.

Johnson DA, Argoff CE.

J Fam Pract. 2015 Dec;64(12 Suppl):S4-9. Review.

PMID:
26845012
23.

Yes, You Can Manage Chronic Pain.

Argoff CE.

Med Clin North Am. 2016 Jan;100(1):xix-xx. doi: 10.1016/j.mcna.2015.10.001. No abstract available.

PMID:
26614729
24.

Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation.

Argoff CE, Brennan MJ, Camilleri M, Davies A, Fudin J, Galluzzi KE, Gudin J, Lembo A, Stanos SP, Webster LR.

Pain Med. 2015 Dec;16(12):2324-37. doi: 10.1111/pme.12937. Epub 2015 Nov 19. Review.

25.

Relationship between change in pain intensity and functional outcomes in patients with chronic pain receiving twice daily extended-release hydrocodone bitartrate.

Argoff C, Arnstein P, Stanos S, Robinson CY, Galer BS, Gould E, Gammaitoni A.

J Opioid Manag. 2015 Sep-Oct;11(5):417-24. doi: 10.5055/jom.2015.0291.

PMID:
26535969
26.

The Effect of High-Frequency Stimulation on Sensory Thresholds in Chronic Pain Patients.

Youn Y, Smith H, Morris B, Argoff C, Pilitsis JG.

Stereotact Funct Neurosurg. 2015;93(5):355-9. doi: 10.1159/000438998. Epub 2015 Oct 8.

27.

Opioids for chronic noncancer pain: A position paper of the American Academy of Neurology.

Katz JA, Swerdloff MA, Brass SD, Argoff CE, Markman J, Backonja M, Katz N.

Neurology. 2015 Apr 7;84(14):1503-4. doi: 10.1212/WNL.0000000000001485. No abstract available.

PMID:
25846999
28.

Prior Opioid Use Does Not Impact the Response to Pregabalin in Patients With Fibromyalgia.

Argoff CE, Clair A, Emir B, Whalen E, Ortiz M, Pauer L.

Clin J Pain. 2016 Jul;32(7):555-61. doi: 10.1097/AJP.0000000000000232.

PMID:
25756560
29.

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part Two: Treatments and Applications.

Peppin JF, Albrecht PJ, Argoff C, Gustorff B, Pappagallo M, Rice FL, Wallace MS.

Pain Ther. 2015 Jun;4(1):33-50. doi: 10.1007/s40122-015-0032-z. Epub 2015 Jan 29.

30.

Skin Matters: A Review of Topical Treatments for Chronic Pain. Part One: Skin Physiology and Delivery Systems.

Peppin JF, Albrecht PJ, Argoff C, Gustorff B, Pappagallo M, Rice FL, Wallace MS.

Pain Ther. 2015 Jun;4(1):17-32. doi: 10.1007/s40122-015-0031-0. Epub 2015 Jan 28.

31.

Intrathecal opioids for chronic pain: a call for evidence.

Harden RN, Argoff CE, Williams DA.

Pain Med. 2014 Nov;15(11):1823-4. doi: 10.1111/pme.12576. Epub 2014 Oct 3. No abstract available.

32.

Patients with chronic pain and dysphagia (CPD): unmet medical needs and pharmacologic treatment options.

Argoff CE, Kopecky EA.

Curr Med Res Opin. 2014 Dec;30(12):2543-59. doi: 10.1185/03007995.2014.967388. Epub 2014 Nov 4. Review.

PMID:
25244248
33.

The use of opioid analgesics for chronic pain: minimizing the risk for harm.

Argoff CE, Viscusi ER.

Am J Gastroenterol Suppl. 2014 Sep 10;2(1):3-8. doi: 10.1038/ajgsup.2014.3. Review.

PMID:
25207607
34.

Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence.

Argoff CE, Kahan M, Sellers EM.

J Opioid Manag. 2014 Mar-Apr;10(2):119-34. doi: 10.5055/jom.2014.0201. Review.

PMID:
24715667
35.
36.

Topical analgesics in the management of acute and chronic pain. Introduction.

Argoff CE.

Postgrad Med. 2013 Jul;125(4 Suppl 1):3-6. doi: 10.3810/pgm.2013.07.suppl.2695. No abstract available.

PMID:
24141026
37.

Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.

Gibofsky A, Silberstein S, Argoff C, Daniels S, Jensen S, Young CL.

Postgrad Med. 2013 Sep;125(5):130-8. doi: 10.3810/pgm.2013.09.2693.

PMID:
24113671
38.

Advances in topical analgesics.

Anitescu M, Benzon HT, Argoff CE.

Curr Opin Anaesthesiol. 2013 Oct;26(5):555-61. doi: 10.1097/01.aco.0000432514.00446.22. Review.

PMID:
23995062
39.

Recent management advances in acute postoperative pain.

Argoff CE.

Pain Pract. 2014 Jun;14(5):477-87. doi: 10.1111/papr.12108. Epub 2013 Aug 15. Review.

PMID:
23945010
40.

Evidence-based guidance for the management of postherpetic neuralgia in primary care.

Harden RN, Kaye AD, Kintanar T, Argoff CE.

Postgrad Med. 2013 Jul;125(4):191-202. doi: 10.3810/pgm.2013.07.2690. Review.

PMID:
23933906
41.

Validity testing of patient objections to acceptance of tamper-resistant opioid formulations.

Argoff CE, Stanos SP, Wieman MS.

J Pain Res. 2013 May 16;6:367-73. doi: 10.2147/JPR.S37343. Print 2013.

42.

Excessive peptidergic sensory innervation of cutaneous arteriole-venule shunts (AVS) in the palmar glabrous skin of fibromyalgia patients: implications for widespread deep tissue pain and fatigue.

Albrecht PJ, Hou Q, Argoff CE, Storey JR, Wymer JP, Rice FL.

Pain Med. 2013 Jun;14(6):895-915. doi: 10.1111/pme.12139. Epub 2013 May 20.

PMID:
23691965
43.

Author response.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C.

Neurology. 2013 Feb 26;80(9):868-9. No abstract available.

PMID:
23565553
44.

Topical analgesics in the management of acute and chronic pain.

Argoff CE.

Mayo Clin Proc. 2013 Feb;88(2):195-205. doi: 10.1016/j.mayocp.2012.11.015. Review.

PMID:
23374622
45.

American Academy of Pain Medicine response to PROP petition to the FDA that seeks to limit pain medications for legitimate noncancer pain sufferers.

Fine P, Webster L, Argoff C.

Pain Med. 2012 Oct;13(10):1259-64. doi: 10.1111/j.1526-4637.2012.01493.x. Epub 2012 Sep 21. No abstract available.

PMID:
22998637
46.

Intrathecal opioids for chronic pain: a call for evidence.

Harden RN, Argoff CE, Williams DA.

Pain Med. 2012 Aug;13(8):987-8. doi: 10.1111/j.1526-4637.2012.01456.x. No abstract available.

PMID:
22897774
47.

Clinical development of a once-daily gastroretentive formulation of gabapentin for treatment of postherpetic neuralgia: an overview.

Argoff CE, Chen C, Cowles VE.

Expert Opin Drug Deliv. 2012 Sep;9(9):1147-60. doi: 10.1517/17425247.2012.709231. Epub 2012 Jul 18. Review.

PMID:
22809245
48.

Recommendations for urine drug monitoring as a component of opioid therapy in the treatment of chronic pain.

Peppin JF, Passik SD, Couto JE, Fine PG, Christo PJ, Argoff C, Aronoff GM, Bennett D, Cheatle MD, Slevin KA, Goldfarb NI.

Pain Med. 2012 Jul;13(7):886-96. doi: 10.1111/j.1526-4637.2012.01414.x. Epub 2012 Jun 13. Review.

PMID:
22694154
49.

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Holland S, Silberstein SD, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 2012 Apr 24;78(17):1346-53. doi: 10.1212/WNL.0b013e3182535d0c. Review.

50.

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E; Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society.

Neurology. 2012 Apr 24;78(17):1337-45. doi: 10.1212/WNL.0b013e3182535d20. Review. Erratum in: Neurology. 2013 Feb 26;80(9):871.

Supplemental Content

Loading ...
Support Center